Novo Nordisk today announced disappointing topline results for two clinical trials, EVOKE and EVOKE+, of their GLP-1 agonist semaglutide for Alzheimer’s disease. Semaglutide is approved for treatment of diabetes and…
더 읽어보기
The post Sharing Alzheimer’s Education to the Spanish-Speaking Community in Southern California appeared first on UCI MIND.
더 읽어보기
Drs. Kevin Beier and Elizabeth Head, both faculty members of UCI MIND, along with co-investigators Drs. Liz Chrastil and Jing Zhang have been awarded a 4 year NIH grant to…
더 읽어보기
UCI MIND is in the spotlight again with the announcement of large collaborative NIA grant to study LATE. Read the article in the UC Irvine News The post UCI MIND…
더 읽어보기